Abstract: A pharmaceutical composition (F) comprising at least one pharmaceutical active principle and as thickener a composition (CA) in the form of an emulsion of the self-invertible water-in-oil type comprising, per 100% of its mass, a mass content of greater than or equal to 20% of a polymer (P) consisting of monomer units derived from partially or totally salified glutamic acid (GA), and of units derived from at least one crosslinking agent (XLA) bearing at least two glycidyl functions.

Abstract: Composition (CA) in the form of a self-reversible water-in-oil-type emulsion comprising, for 100% of its mass, a mass content of greater than or equal to 20% of a polymer (P) consisting of monomeric units derived from glutamic acid (GA), partially or totally salified, and units derived from at least one crosslinking agent (AR) bearing at least two glycidyl functions.

Abstract: Detergent composition (F) for domestic or industrial use, comprising at least one detergent surfactant and, as thickening agent, a composition (CA) in the form of a self-reversible water-in-oil-type emulsion comprising, for 100% of its mass, a mass content of greater than or equal to 20% of a polymer (P) consisting of monomer units derived from glutamic acid (GA), partially or totally salified, and units derived from at least one cross-linking agent (AR) bearing at least two glycidyl functions.

Abstract: Disclosed is a liquid detergent composition (F) for domestic or industrial use, comprising at least one detergent surfactant and, as thickening agent, a polymer (P) in the form of a pulverulent solid consisting of monomeric units derived from partially or totally salified glutamic acid (GA), and monomer units of at least one crosslinking agent (AR) having at least two glycidic functions.

Abstract: Disclosed is a pharmaceutical composition (F) for topical use, comprising at least one active pharmaceutical ingredient and, as thickening agent, a polymer (P) in the form of a pulverulent solid consisting of monomeric units derived from partially or totally salified glutamic acid (GA) and monomer units of at least one crosslinking agent (AR) having at least two glycidyl functions.

Abstract: Disclosed is a polymer (P) in the form of a pulverulent solid consisting of monomeric units derived from partially or totally solidified glutamic acid (GA), and monomer units of at least one crosslinking agent (AR) having at least two glycidyl functions.

Abstract: Disclosed is a vaccine adjuvant including at least one inverse microlatex, the inverse microlatex including at least one oil, at least one surfactant, at least one polymer such as, for example, a polyacrylate that is totally or partially neutralized in the form of alkali metal salts or ammonium salt, the vaccine adjuvant being entirely sterilizable by filtration or by passing through the heat of an autoclave and emulsifiable in one step with the aqueous phase including only a vaccine antigen.